Lumida
/NWBO
⌘K
Northwest Biotherapeutics Inc

Northwest Biotherapeutics Inc

NWBO
$0.17USD+2.21%+0.00 today

MARKET CAP

288.1M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$0
STATEMENT·Income statement
USD · GAAP
METRICFY 2013FY 2014FY 2015TREND
Sales, Adj.$809,000$1.5M$1.7M
YoY %+79.7%+19.6%
P / Sales
EV / Sales
Gross Profit, Adj.$809,000$1.5M$1.7M
YoY %+79.7%+19.6%
Margin %100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-55.5M$-101.1M$-126.2M
YoY %-26.6%-82.3%-24.8%
Margin %-6855.7%-6955.4%-7258.7%
EV / EBITDA
EBIT$-55.5M$-101.1M$-126.3M
YoY %-26.6%-82.3%-24.9%
Margin %-6857.1%-6956.2%-7261.9%
EV / EBIT
Net Income$-65.8M$-135.6M$-114.7M
YoY %+2.3%-106.2%+15.4%
Net Margin-8132.1%-9328.3%-6598.1%
EPS (GAAP)-$2.00-$2.29-$1.48
YoY %+65.0%-14.5%+35.4%